Get ahead of the Medicare Supplement market now.
Talk to us about a proof-of-concept study to see how it can bring unprecedented value to your Medicare Supplement business.
Irix
Risk Score | Morbidity
Take a larger share of the Medicare Supplement market.
Get a real-time snapshot of individual health risk in seconds.
The predictive model that revolutionized underwriting with a simple numerical score is now being used to instantly assess morbidity in Medicare Supplement applicants.
Upend the status quo and take a larger share of the highly competitive Medicare Supplement market with Risk Score. Using a single risk metric, you’ll find efficiencies and cost-savings that fight back against rate compression and increasing loss ratios. And with Risk Score’s predictive accuracy, you’ll pay less in claims and improve profitability. Retrospective studies show astounding benefit-to-cost figures.
What you may be missing without Risk Score
- Better risk selection
- The ability to issue more underwritten business
- Optimized policy pricing
- Decreased decline rates
- Automated decisioning
See the bigger picture with Risk Score
Risk Score consistently interprets the combination of prescription histories and medical claims data to predict morbidity with rapid-fire speed and proven accuracy. It stratifies risk within a given medical condition, detects unintuitive patterns you might otherwise miss, and brings ease to point-of-sale decisions. You can confidently select the best risks in just moments.
Request a demo
Related topics
White Paper
Those applicants you declined? Their mortality matters more than you think
Partner Re makes clever use of Irix® Risk Score to test industry assumptions about decline mortality.
Read more
Article
Six planes down: The magnitude of nicotine’s impact on mortality
Is it time to rethink tobacco underwriting guidelines?
Read more
Article
Jet-declining severe obesity is costing life insurance carriers business
You can confidently cover millions more Americans without taking on additional risk.
Read more